文献速递免疫规划传染病防控与疫情报告

大流行前佐剂H5N8流感疫苗的安全性及体液细胞免疫应答

Safety, humoral and cellular immune responses to a pre-pandemic adjuvanted influenza A (H5N8) vaccine.
PubMed 文献 · Vaccine · 2026-09-04

本研究在大鼠和兔中评估IB160佐剂H5N8流感疫苗(15 μg HA/剂)的非临床安全性与免疫原性。结果显示疫苗局部和全身耐受良好,未影响重要器官功能,并诱导强而持久的体液和细胞免疫应答。

要点

  • H5N8疫苗15 μg HA/剂加IB160佐剂在大鼠和兔中耐受良好。
  • 疫苗诱导的HAI抗体滴度在各组均达保护水平且持久。
  • 疫苗诱导抗原特异性T细胞产生IL-2和TNF的细胞免疫应答。

核心结论

  • IB160佐剂H5N8疫苗局部和全身耐受良好,不损害重要器官功能,并诱导强而持久的体液和细胞免疫应答。

研究设计与样本

  • 雄性及雌性Wistar大鼠和新西兰兔接受两剂肌内注射H5N8疫苗(15 μg HA/剂,IB160水包油佐剂),观察14、28和90天。

主要发现

  • 未见全身合并症、中枢神经系统改变或相关临床体征,血液学参数在正常范围内,总白细胞及分类计数仅轻微波动(<1%总白细胞)。
  • 尿素和肝转氨酶轻度生化变化与组织病理学改变无相关性。
  • 疫苗免疫后各组均达到保护性HAI抗体滴度,抗体水平随时间下降(尤其雄性)但仍显著高于基线。
  • 加强免疫后脾细胞培养中抗原特异性T淋巴细胞产生IL-2和TNF,证实疫苗诱导特异性细胞免疫应答。

临床怎么用

  • 该非临床安全性及免疫原性结果支持进一步开展H5N8佐剂疫苗的人体临床安全性试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Highly pathogenic avian influenza (HPAI) A(H5) viruses can be transmitted from infected birds to various mammalian species, including humans. Avian influenza viruses (AIVs), members of the Orthomyxoviridae family, possess segmented RNA genomes prone to reassortment, favoring the emergence of novel genetic traits that may alter transmissibility, pathogenicity, and antigenicity. Although no sustained human-to-human transmission has been reported, the potential adaptation of these viruses poses a significant pandemic threat. This study aimed to evaluate the non-clinical safety, toxicity, and humoral immune responses induced by an adjuvanted H5 influenza vaccine in rats and rabbits, to support future clinical safety trials in humans. Male and female Wistar rats and New Zealand rabbits were observed for 14, 28, and 90 days after receiving two intramuscular doses of the H5N8 vaccine (15 μg HA/dose) formulated with the IB160 oil-in-water emulsion adjuvant. No systemic comorbidities, central nervous system alterations, or relevant clinical signs were observed. Hematological parameters remained within normal ranges, with total and differential leukocyte counts showing only minor fluctuations (<1% of total leukocytes). Mild biochemical variations in urea and hepatic transaminase levels were not correlated with histopathological alterations. The vaccine elicited a robust humoral response soon after immunization, with all groups reaching protective HAI-antibody titers. Although antibody levels declined over time, particularly in males, they remained significantly above baseline, indicating durable immunological memory. Furthermore, the vaccine induced a specific cellular immune response, confirmed by IL-2 and TNF production by antigen-specific T lymphocytes in splenic cell cultures after the booster dose. In conclusion, the H5N8 vaccine with the IB160 adjuvant was well tolerated locally and systemically, without compromising vital organ function. The safety and immunogenicity findings are consistent with expectations for adjuvanted influenza vaccines, demonstrating strong and durable humoral and cellular immune responses.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Maria DA, Martins IM, Porto GPM, et al. Safety, humoral and cellular immune responses to a pre-pandemic adjuvanted influenza A (H5N8) vaccine. Vaccine. 2026. PMID: 42696822. doi:10.1016/j.vaccine.2026.129049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。